Clinical Trial Update: Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Hexvix fluorescence cystoscopy to improve detection and reduce early recurrence of bladder cancer has completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Hexvix (hexaminolevulinate hydrochloride)

Snippet

Sponsor: Photocure | Conditions: Bladder Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-10-11